Development of mrna vaccine to licensure for the prevention of covid-19. Clin 0001 - pre-award cost, clin 0002 - development of mrna vaccine to BLA and clin 0003 - domestic manufacturing scale-out
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50120C00034
- Awardee
-
Modernatx, Inc. UEI WJYNZ8AK2D47
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $1,754,345,480
Award facts
- Opportunity
-
- 15100SOL00003 Solicitation number
- Contract value 100% obligated
- $1,754,345,480.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Cambridge, MA 02139, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $47,744,137 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $308,495,451 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $144,140,941 | |
| Funding Only Action | $236,364,615 | |
| Funding Only Action | $62,705,357 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Other Administrative Action | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $471,596,459 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $53,000,000 | |
| Original award | $430,298,520 |
Show all 24
About this award
This is a $1,754,345,480.45 definitive cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Moderna, Inc. for the development of an mRNA vaccine to licensure for the prevention of COVID-19. The contract includes pre-award costs, development of the mRNA vaccine to Biologics License Application (BLA), and domestic manufacturing scale-out. This award does not have a set-aside designation. Moderna, a for-profit pharmaceutical manufacturer, has received prior federal awards from agencies such as the Department of Veterans Affairs, Defense Advanced Research Projects Agency, and Department of Health and Human Services for COVID-19 mRNA vaccine development and manufacturing capacity expansion.
Subawards
Show all 36
Quick answers
Who was awarded contract 75A50120C00034?
75A50120C00034 was awarded to Modernatx, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on April 3, 2020.
How much is contract 75A50120C00034 worth?
The government has obligated $1,754,345,480 on 75A50120C00034.
Was contract 75A50120C00034 competed?
The extent of competition for 75A50120C00034 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award